Shots:
AI is moving drug development from computation to clinical confidence, showing how it now guides target discovery, molecule design, patient stratification, and trial planning while turning fragmented biomedical data into decision-ready insight that reduces risk, cost, and failure rates.
Trust, transparency, and regulation define AI’s real breakthrough, as the focus shifts beyond speed toward…
